GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Statera BioPharma Inc (STU:7CB) » Definitions » Common Stock

Statera BioPharma (STU:7CB) Common Stock : €0.26 Mil (As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Statera BioPharma Common Stock?

Statera BioPharma's quarterly common stock increased from Mar. 2022 (€0.23 Mil) to Jun. 2022 (€0.24 Mil) and increased from Jun. 2022 (€0.24 Mil) to Sep. 2022 (€0.26 Mil).

Statera BioPharma's annual common stock increased from Dec. 2019 (€0.02 Mil) to Dec. 2020 (€0.13 Mil) and increased from Dec. 2020 (€0.13 Mil) to Dec. 2021 (€0.16 Mil).


Statera BioPharma Common Stock Historical Data

The historical data trend for Statera BioPharma's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Statera BioPharma Common Stock Chart

Statera BioPharma Annual Data
Trend Dec19 Dec20 Dec21
Common Stock
0.02 0.13 0.16

Statera BioPharma Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.14 0.16 0.23 0.24 0.26

Statera BioPharma Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Statera BioPharma (STU:7CB) Business Description

Traded in Other Exchanges
N/A
Address
4333 Corbett Drive, Suite 1082, Fort Collins, CO, USA, 80525
Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.

Statera BioPharma (STU:7CB) Headlines

No Headlines